Revenio Group Corporation - Asset Resilience Ratio
Revenio Group Corporation (REG1V) has an Asset Resilience Ratio of 17.40% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. For the complete balance sheet picture, see Revenio Group Corporation asset portfolio.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2022)
This chart shows how Revenio Group Corporation's Asset Resilience Ratio has changed over time. Read Revenio Group Corporation (REG1V) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Revenio Group Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. See Revenio Group Corporation (REG1V) liquidity interval to measure how many days the company can operate on defensive assets alone.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €26.20 Million | 17.4% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €26.20 Million | 17.40% |
Asset Resilience Insights
- Good Liquidity Position: Revenio Group Corporation maintains a healthy 17.40% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Revenio Group Corporation Industry Peers by Asset Resilience Ratio
Compare Revenio Group Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Establishment Labs Holdings Inc
NASDAQ:ESTA |
Medical Devices | 0.00% |
|
SonoScape Medical Corp
SHE:300633 |
Medical Devices | 0.21% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Guerbet S. A.
PA:GBT |
Medical Devices | 3.05% |
Annual Asset Resilience Ratio for Revenio Group Corporation (2000–2022)
The table below shows the annual Asset Resilience Ratio data for Revenio Group Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 23.43% | €31.89 Million ≈ $37.28 Million |
€136.09 Million ≈ $159.10 Million |
+3.19pp |
| 2021-12-31 | 20.24% | €25.22 Million ≈ $29.48 Million |
€124.58 Million ≈ $145.65 Million |
-26.51pp |
| 2009-12-31 | 46.75% | €12.42 Million ≈ $14.52 Million |
€26.57 Million ≈ $31.06 Million |
+0.93pp |
| 2008-12-31 | 45.82% | €13.26 Million ≈ $15.50 Million |
€28.94 Million ≈ $33.83 Million |
+43.99pp |
| 2001-12-31 | 1.83% | €453.00K ≈ $529.60K |
€24.79 Million ≈ $28.98 Million |
-2.49pp |
| 2001-09-30 | 4.32% | €1.71 Million ≈ $2.00 Million |
€39.63 Million ≈ $46.34 Million |
-6.94pp |
| 2000-12-31 | 11.27% | €5.04 Million ≈ $5.90 Million |
€44.76 Million ≈ $52.33 Million |
-- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more